Company Description
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source.
It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications.
The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox.
CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting.
It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups.
In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations.
Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.
| Country | Israel |
| Founded | 2011 |
| IPO Date | Aug 21, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 197 |
| CEO | Erez Meltzer |
Contact Details
Address: 94 Shlomo Shmeltzer Road, Ofer Tech Park Petah Tikva, 4970602 Israel | |
| Phone | 972 3 373 59202 |
| Website | nanox.vision |
Stock Details
| Ticker Symbol | NNOX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.00 |
| CIK Code | 0001795251 |
| CUSIP Number | M70700105 |
| ISIN Number | IL0011681371 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Elli Yuz | Chief Executive Officer OF USARAD Holdings Inc. |
| Erez I. Meltzer | Chief Executive Officer and Acting Chairman of the Board |
| Ran Daniel | Chief Financial Officer |
| Tamar Aharon Cohen | Executive Vice President and Chief Marketing Officer |
| James M. Dara | GM of Source and Services Division and Head of Nanox USA |
| Marina Gofman Feler | Chief Legal Officer |
| Dr. Ilung Kim Ph.D. | Head of Nanox Korea |
| Gali Yahav Attias | Chief of Corporate Resources |
| Dr. Michael Yuz M.D., MBA | President and CMO, USARAD Holdings Inc. |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | Filing |
| Apr 30, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Apr 20, 2026 | 6-K | Report of foreign issuer |
| Mar 30, 2026 | EFFECT | Notice of Effectiveness |
| Mar 26, 2026 | F-3/A | Filing |
| Mar 23, 2026 | UPLOAD | Filing |
| Mar 13, 2026 | F-3 | Filing |
| Feb 3, 2026 | 6-K | Report of foreign issuer |
| Dec 29, 2025 | 6-K | Report of foreign issuer |
| Dec 22, 2025 | 6-K | Report of foreign issuer |